Grünenthal Group Revenue and Competitors

Worthington, IA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Grünenthal Group's estimated annual revenue is currently $1.1B per year.(i)
  • Grünenthal Group's estimated revenue per employee is $201,000

Employee Data

  • Grünenthal Group has 5343 Employees.(i)
  • Grünenthal Group grew their employee count by 8% last year.

Grünenthal Group's People

NameTitleEmail/Phone
1
CFO BrazilReveal Email/Phone
2
Head Integration & Alliance | VPReveal Email/Phone
3
CIOReveal Email/Phone
4
Site Director, VP (Grünenthal, Andrómaco, Silesia)Reveal Email/Phone
5
Head Market AccessReveal Email/Phone
6
Head Archive OperationsReveal Email/Phone
7
Head Supply Chain LatAm AffiliatesReveal Email/Phone
8
Head Bioinformatics and Disease UnderstandingReveal Email/Phone
9
Head Data & AnalyticsReveal Email/Phone
10
Head Sales CAMRDReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$28.4M5733%$75.8MN/A
#2
$1.2M6-73%N/AN/A
#3
$26.3M1313%N/AN/A
#4
$33.4M1662%N/AN/A
#5
$1073.9M53438%N/AN/A
#6
$9M4510%N/AN/A
#7
$20.5M10252%N/AN/A
#8
$20.1M10037%N/AN/A
#9
$9.2M4610%N/AN/A
#10
$3M15-56%N/AN/A
Add Company

What Is Grünenthal Group?

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://careers.grunenthal.com/ Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp Europe: Pain, (prescriptive drugs), Further indications, Latin America: Pain, Central Nervous System, Gynecology, Further indications, R&D: Pain, Inflammation

keywords:N/A

N/A

Total Funding

5343

Number of Employees

$1.1B

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Grünenthal Group News

2022-04-17 - Global Triptan Market 2022 Trending Vendors – GSK, Teva, Pfizer ...

GSK; Teva; Pfizer; Novartis; Sun Pharma; Grunenthal; Endo Pharmaceuticals; Merck; J & J ... Additional relevant market-related groups.

2022-03-30 - Mesoblast Limited (MESO) Q1 2022 Earnings Call Transcript

... to support our relationship with our partner in Europe Grunenthal. ... In that group of patients, which accounted for about 70% of all...

2022-03-30 - Grünenthal and NovaQuest Enter Agreement to Advance the ...

Osteoarthritis (OA) can be defined as a group of distinct but ... More information: www.grunenthal.com ... LinkedIn: Grunenthal Group

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2989.9M8717N/AN/A